Molecular Analysis of Thoracic Malignancies

Launched by STANFORD UNIVERSITY · Jun 29, 2011

Keywords

ClinConnect Summary

In the United States, an estimated 222,520 lung and bronchus cancers will be diagnosed in 2010, and 157,300 people will die of this disease. Therefore, there is an urgent need for safer and more effective therapies for lung cancer.1 Lung cancer falls into two major classifications, non-small cell lung cancer (NSCLC) which accounts for approximately 87%, and small cell lung cancer (SCLC), which accounts for the remainder. Thymomas are the most common tumors of the anterior mediastinum, and typically occur in adults older than 40 years. While surgical resection and radiation often effectively...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1.Histologically proven diagnosis of non-small cell lung cancer, small cell lung cancer, thymoma, thymic carcinoma, mesothelioma, or carcinoma of unknown primary consistent with the presentation of a primary thoracic malignancy.
• • 2.18 years of age or older.
• • 3.Ability to understand and the willingness to sign a written informed consent document.